ARCHIVES

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

This article is from The Cancer Letter archive.

Vol. 38 No. 37 | October 5, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

Mammography Had Limited Impact Among Swedish Women Age 40-69

July 27, 2012

NIH Carcinogen Guidelines Offered

April 24, 1981

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003